Lindsey Allen | Head of Investor Relations and Communications |
Justin Klee | Co-Chief Executive Officer and Co-Founder |
Margaret Olinger | Global Head of Commercial and CCO |
James Frates | Chief Financial Officer |
Josh Cohen | Co-Chief Executive Officer and Co-Founder |
Geoff Meacham | Bank of America |
Umer Raffat | Evercore ISI |
Neena Bitritto-Garg | Citi |
Corinne Jenkins | Goldman Sachs |
Marc Goodman | SVB Securities |
Ananda Ghosh | H.C. Wainwright |
Good afternoon. My name is Gary, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions.